Literature DB >> 22643910

MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).

Aida Gordanpour1, Robert K Nam, Linda Sugar, Stephanie Bacopulos, Arun Seth.   

Abstract

MicroRNAs (miRNAs) are single-stranded, 18-24 nucleotide long, non-coding RNA molecules. They are involved in virtually every cellular process including development, apoptosis, and cell cycle regulation. MiRNAs are estimated to regulate the expression of 30% to 90% of human genes by binding to their target messenger RNAs (mRNAs). Widespread dysregulation of miRNAs has been reported in various diseases and cancer subtypes. Due to their prevalence and unique structure, these small molecules are likely to be the next generation of biomarkers, therapeutic agents and/or targets. Methods used to investigate miRNA expression include SYBR green I dye-based as well as Taqman-probe based qPCR. If miRNAs are to be effectively used in the clinical setting, it is imperative that their detection in fresh and/or archived clinical samples be accurate, reproducible, and specific. qPCR has been widely used for validating expression of miRNAs in whole genome analyses such as microarray studies. The samples used in this protocol were from patients who underwent radical prostatectomy for clinically localized prostate cancer; however other tissues and cell lines can be substituted in. Prostate specimens were snap-frozen in liquid nitrogen after resection. Clinical variables and follow-up information for each patient were collected for subsequent analysis. Quantification of miRNA levels in prostate tumor samples. The main steps in qPCR analysis of tumors are: Total RNA extraction, cDNA synthesis, and detection of qPCR products using miRNA-specific primers. Total RNA, which includes mRNA, miRNA, and other small RNAs were extracted from specimens using TRIzol reagent. Qiagen's miScript System was used to synthesize cDNA and perform qPCR (Figure 1). Endogenous miRNAs are not polyadenylated, therefore during the reverse transcription process, a poly(A) polymerase polyadenylates the miRNA. The miRNA is used as a template to synthesize cDNA using oligo-dT and Reverse Transcriptase. A universal tag sequence on the 5' end of oligo-dT primers facilitates the amplification of cDNA in the PCR step. PCR product amplification is detected by the level of fluorescence emitted by SYBR Green, a dye which intercalates into double stranded DNA. Specific miRNA primers, along with a Universal Primer that binds to the universal tag sequence will amplify specific miRNA sequences. The miScript Primer Assays are available for over a thousand human-specific miRNAs, and hundreds of murine-specific miRNAs. Relative quantification method was used here to quantify the expression of miRNAs. To correct for variability amongst different samples, expression levels of a target miRNA is normalized to the expression levels of a reference gene. The choice of a gene on which to normalize the expression of targets is critical in relative quantification method of analysis. Examples of reference genes typically used in this capacity are the small RNAs RNU6B, RNU44, and RNU48 as they are considered to be stably expressed across most samples. In this protocol, RNU6B is used as the reference gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22643910      PMCID: PMC3466958          DOI: 10.3791/3874

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MicroRNAs in plants.

Authors:  Brenda J Reinhart; Earl G Weinstein; Matthew W Rhoades; Bonnie Bartel; David P Bartel
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

3.  miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.

Authors:  Aida Gordanpour; Aleksandra Stanimirovic; Robert K Nam; Carlos S Moreno; Christopher Sherman; Linda Sugar; Arun Seth
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

Review 4.  MicroRNAs and prostate cancer.

Authors:  Valeria Coppola; Ruggero De Maria; Désirée Bonci
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

5.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.

Authors:  Stefan Ambs; Robyn L Prueitt; Ming Yi; Robert S Hudson; Tiffany M Howe; Fabio Petrocca; Tiffany A Wallace; Chang-Gong Liu; Stefano Volinia; George A Calin; Harris G Yfantis; Robert M Stephens; Carlo M Croce
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

6.  The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism.

Authors:  Peizhang Xu; Stephanie Y Vernooy; Ming Guo; Bruce A Hay
Journal:  Curr Biol       Date:  2003-04-29       Impact factor: 10.834

Review 7.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

8.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

Review 9.  Control of cell proliferation pathways by microRNAs.

Authors:  María José Bueno; Ignacio Pérez de Castro; Marcos Malumbres
Journal:  Cell Cycle       Date:  2008-10-20       Impact factor: 4.534

10.  Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.

Authors:  R K Nam; L Sugar; W Yang; S Srivastava; L H Klotz; L-Y Yang; A Stanimirovic; E Encioiu; M Neill; D A Loblaw; J Trachtenberg; S A Narod; A Seth
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

View more
  8 in total

1.  Generation of genomic deletions in mammalian cell lines via CRISPR/Cas9.

Authors:  Daniel E Bauer; Matthew C Canver; Stuart H Orkin
Journal:  J Vis Exp       Date:  2015-01-03       Impact factor: 1.355

2.  Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.

Authors:  H Lawlor; A Meunier; N McDermott; T H Lynch; L Marignol
Journal:  Tumour Biol       Date:  2015-03-07

3.  Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.

Authors:  Darina Kachakova; Atanaska Mitkova; Elenko Popov; Ivan Popov; Alexandrina Vlahova; Tihomir Dikov; Svetlana Christova; Vanio Mitev; Chavdar Slavov; Radka Kaneva
Journal:  DNA Cell Biol       Date:  2014-12-18       Impact factor: 3.311

Review 4.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

5.  Loss expression of micro ribonucleic acid (miRNA)-200c induces adverse post-surgical prognosis of advanced stage non-small cell lung carcinoma and its potential relationship with ETAR messenger RNA.

Authors:  Jinpeng Zhao; Yandong Zhao; Zizong Wang; Yunpeng Xuan; Yiren Luo; Wenjie Jiao
Journal:  Thorac Cancer       Date:  2015-07-02       Impact factor: 3.500

6.  An Expanded Role for HLA Genes: HLA-B Encodes a microRNA that Regulates IgA and Other Immune Response Transcripts.

Authors:  Nilesh Chitnis; Peter M Clark; Malek Kamoun; Catherine Stolle; F Brad Johnson; Dimitri S Monos
Journal:  Front Immunol       Date:  2017-05-19       Impact factor: 7.561

7.  MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).

Authors:  Yong Zhu; Xing Wen; Peng Zhao
Journal:  Med Sci Monit       Date:  2018-06-02

8.  Large oncosomes mediate intercellular transfer of functional microRNA.

Authors:  Matteo Morello; Valentina R Minciacchi; Paola de Candia; Julie Yang; Edwin Posadas; Hyung Kim; Duncan Griffiths; Neil Bhowmick; Leland W K Chung; Paolo Gandellini; Michael R Freeman; Francesca Demichelis; Dolores Di Vizio
Journal:  Cell Cycle       Date:  2013-09-23       Impact factor: 4.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.